(4R)-3,5,5-trimethyl-4-[(3R)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybutyl]cyclohex-2-en-1-one

Details

Top
Internal ID 4f8854d8-6974-4400-aea8-bfb2fb963344
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty acyl glycosides > Fatty acyl glycosides of mono- and disaccharides
IUPAC Name (4R)-3,5,5-trimethyl-4-[(3R)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybutyl]cyclohex-2-en-1-one
SMILES (Canonical) CC1=CC(=O)CC(C1CCC(C)OC2C(C(C(C(O2)COC3C(C(C(CO3)O)O)O)O)O)O)(C)C
SMILES (Isomeric) CC1=CC(=O)CC([C@H]1CC[C@@H](C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@H](CO3)O)O)O)O)O)O)(C)C
InChI InChI=1S/C24H40O11/c1-11-7-13(25)8-24(3,4)14(11)6-5-12(2)34-23-21(31)19(29)18(28)16(35-23)10-33-22-20(30)17(27)15(26)9-32-22/h7,12,14-23,26-31H,5-6,8-10H2,1-4H3/t12-,14+,15+,16-,17+,18-,19+,20-,21-,22+,23-/m1/s1
InChI Key LYJZPTUVRHPVNB-PTPXYPNHSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C24H40O11
Molecular Weight 504.60 g/mol
Exact Mass 504.25706209 g/mol
Topological Polar Surface Area (TPSA) 175.00 Ų
XlogP -1.80
Atomic LogP (AlogP) -1.00
H-Bond Acceptor 11
H-Bond Donor 6
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (4R)-3,5,5-trimethyl-4-[(3R)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybutyl]cyclohex-2-en-1-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.5841 58.41%
Caco-2 - 0.8415 84.15%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability - 0.7000 70.00%
Subcellular localzation Mitochondria 0.8861 88.61%
OATP2B1 inhibitior - 0.7191 71.91%
OATP1B1 inhibitior + 0.8773 87.73%
OATP1B3 inhibitior - 0.2453 24.53%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7276 72.76%
BSEP inhibitior - 0.6362 63.62%
P-glycoprotein inhibitior - 0.6401 64.01%
P-glycoprotein substrate - 0.5365 53.65%
CYP3A4 substrate + 0.6767 67.67%
CYP2C9 substrate - 0.7898 78.98%
CYP2D6 substrate - 0.8838 88.38%
CYP3A4 inhibition - 0.9604 96.04%
CYP2C9 inhibition - 0.8508 85.08%
CYP2C19 inhibition - 0.8647 86.47%
CYP2D6 inhibition - 0.9422 94.22%
CYP1A2 inhibition - 0.9141 91.41%
CYP2C8 inhibition - 0.7677 76.77%
CYP inhibitory promiscuity - 0.9644 96.44%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6640 66.40%
Eye corrosion - 0.9905 99.05%
Eye irritation - 0.9643 96.43%
Skin irritation - 0.6637 66.37%
Skin corrosion - 0.9565 95.65%
Ames mutagenesis + 0.5322 53.22%
Human Ether-a-go-go-Related Gene inhibition + 0.7705 77.05%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 0.7158 71.58%
skin sensitisation - 0.8499 84.99%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity + 0.7000 70.00%
Mitochondrial toxicity - 0.5000 50.00%
Nephrotoxicity - 0.7663 76.63%
Acute Oral Toxicity (c) III 0.6714 67.14%
Estrogen receptor binding + 0.6040 60.40%
Androgen receptor binding - 0.6223 62.23%
Thyroid receptor binding + 0.5312 53.12%
Glucocorticoid receptor binding + 0.5418 54.18%
Aromatase binding + 0.6343 63.43%
PPAR gamma + 0.5708 57.08%
Honey bee toxicity - 0.7991 79.91%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.7450 74.50%
Fish aquatic toxicity + 0.9569 95.69%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.84% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 97.59% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.06% 96.09%
CHEMBL2581 P07339 Cathepsin D 95.70% 98.95%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 94.04% 85.14%
CHEMBL1293255 P15428 15-hydroxyprostaglandin dehydrogenase [NAD+] 93.06% 83.57%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.92% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.40% 97.09%
CHEMBL3401 O75469 Pregnane X receptor 87.91% 94.73%
CHEMBL220 P22303 Acetylcholinesterase 86.94% 94.45%
CHEMBL1937 Q92769 Histone deacetylase 2 86.13% 94.75%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.32% 95.56%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 84.60% 96.47%
CHEMBL226 P30542 Adenosine A1 receptor 83.62% 95.93%
CHEMBL1871 P10275 Androgen Receptor 83.28% 96.43%
CHEMBL1994 P08235 Mineralocorticoid receptor 82.92% 100.00%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 82.83% 96.77%
CHEMBL2360 P00492 Hypoxanthine-guanine phosphoribosyltransferase 82.39% 87.38%
CHEMBL1806 P11388 DNA topoisomerase II alpha 81.86% 89.00%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 80.22% 90.71%

Cross-Links

Top
PubChem 101450243
NPASS NPC81831
LOTUS LTS0220335
wikiData Q105159395